4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2019 / Single-arm pilot study
In an uncontrolled trial of 60 men with benign prostatic hyperplasia, daily ingestion of an oil-free hydroethanolic pumpkin seed extract for 3 months was followed by an average 30.1% decrease (95% CI: 23.1-37.1) in total International Prostate Symptom Score. Reductions were also noted in nocturia frequency (P < .0001) and postvoid residual urine volume, which shifted from 83.67 mL (95% CI: 58.02-109.3) at baseline to 63.11 mL (95% CI: 45.37-80.85; P = .0394) at 12 weeks.
Leibbrand M, Siefer S, Schön C, et al. J Med Food, 2019. PMID 31017505
2015 / Randomized controlled trial
In a 12-month randomized controlled trial involving 1,431 men aged 50 to 80 years with benign prostatic hyperplasia symptoms, pumpkin seed intake (5 g twice daily) resulted in a higher response rate (58.5%) than placebo (47.3%). Pumpkin seed extract (500 mg twice daily) did not differ significantly from placebo. Both interventions were well tolerated, with pumpkin seeds producing a clinically relevant decrease in symptom scores.
Vahlensieck W, Theurer C, Pfitzer E, et al. Urol Int, 2015. PMID 25196580
2014 / Randomized, double-blind, placebo-controlled trial
A randomized, placebo-controlled, double-blind trial investigated the efficacy of 400 mg per day of pumpkin seed oil (PSO) versus placebo for 24 weeks in 76 men with mild to moderate androgenetic alopecia. After 24 weeks, self-rated improvement and satisfaction scores were higher in the PSO group than in the placebo group (P = 0.013 and P = 0.003, respectively). Men receiving PSO experienced a mean hair count increase of 40%, compared to a 10% increase in the placebo group (P < 0.001). Adverse effects were not significantly different between the groups.
NANO counterpoint →
Cho YH, Lee SY, Jeong DW, et al. Evid Based Complement Alternat Med, 2014. PMID 24864154
2009 / Randomized, double-blind, placebo-controlled trial
A 12-month trial evaluated 47 men with benign prostatic hyperplasia given sweet potato starch (placebo, 320 mg/day), pumpkin seed oil (320 mg/day), saw palmetto oil (320 mg/day), or both oils combined (320 mg/day each). International prostate symptom scores were reduced by 3 months in all active groups. Quality of life scores improved after 3 months with pumpkin seed oil or saw palmetto oil alone, and after 6 months with the combination. Maximal urinary flow rate gradually improved, reaching significance after 6 months with pumpkin seed oil and after 12 months with saw palmetto oil, while prostate volume showed no difference in any group.
NANO counterpoint →
Hong H, Kim CS, Maeng S Nutr Res Pract, 2009. PMID 20098586
2012 / Population-based case-control study
A German case-control study examined the association of phytoestrogen-rich foods, dietary lignans, and fiber intake with breast cancer risk in 2,884 cases and 5,509 controls using a validated food-frequency questionnaire. Consumption of soybeans was associated with a significantly reduced breast cancer risk compared to no consumption (OR = 0.83, 95% CI = 0.70-0.97), as was consumption of sunflower and pumpkin seeds (OR = 0.66, 95% CI = 0.77-0.97). Associations did not differ by estrogen receptor status. No statistically significant associations were found for dietary intake of plant lignans, fiber, or calculated enterolignans.
Shows an association, not proof of cause and effect.
Zaineddin AK, Buck K, Vrieling A, et al. Nutr Cancer, 2012. PMID 22591208